Successful Treatment of Refractory Childhood Pemphgus Vulgaris with Anti-CD20 Monoclonal Antibody (Rituximab)
Author:
Publisher
Wiley
Subject
Dermatology,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1525-1470.2005.00118.x/fullpdf
Reference15 articles.
1. Rituximab therapy and autoimmune disorders: Prospects for anti-B cell therapy
2. Treatment of childhood autoimmune haemolytic anaemia with rituximab
3. Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report
4. Rituximab therapy for multisystem autoimmune diseases in pediatric patients
5. Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rituximab in Childhood and Juvenile Pemphigus Vulgaris: A Systematic Review;Cureus;2024-04-15
2. Use of rituximab in the treatment of pemphigus vulgaris in a juvenile patient;Dermatology Review;2023
3. Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab;Clinical Pediatrics;2022-11-29
4. Childhood Pemphigus Vulgaris during COVID-19 Outbreak Successfully Treated with Prednisone and Azathioprine: A Case Report and Literature Review;Journal of Clinical Medicine;2022-11-21
5. Management of pediatric pemphigus vulgaris with rituximab: A case report and review of the literature;Pediatric Dermatology;2022-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3